Edition:
United States

Nuvectra Corp (NVTR.OQ)

NVTR.OQ on NASDAQ Stock Exchange Global Market

16.92USD
18 May 2018
Change (% chg)

$-0.51 (-2.93%)
Prev Close
$17.43
Open
$17.49
Day's High
$17.73
Day's Low
$16.61
Volume
33,138
Avg. Vol
33,056
52-wk High
$17.75
52-wk Low
$7.65

Chart for

About

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food... (more)

Overall

Beta: --
Market Cap(Mil.): $246.69
Shares Outstanding(Mil.): 14.15
Dividend: --
Yield (%): --

Financials

  NVTR.OQ Industry Sector
P/E (TTM): -- 223.30 32.53
EPS (TTM): -3.55 -- --
ROI: -40.79 -8.07 12.63
ROE: -56.70 -10.87 14.50

BRIEF-Nuvectra Q4 Loss Per Share $0.80

* NUVECTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 06 2018

BRIEF-Nuvectra Secures $45 Million Second Amendment To Existing Loan And Security Agreement

* NUVECTRA SECURES $45 MILLION SECOND AMENDMENT TO EXISTING LOAN AND SECURITY AGREEMENT

Feb 20 2018

BRIEF-Nuvectra Says Public Offering Of 2.83 Mln Shares Priced At $8 Per Share

* SAYS PUBLIC OFFERING OF 2.83 MILLION COMMON SHARES PRICED AT $8.00PER SHARE Source text for Eikon: Further company coverage:

Feb 01 2018

BRIEF-Nuvectra Sees Q4 Revenue $11.5 Mln To $12 Mln

* NUVECTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2017 REVENUE

Jan 08 2018

Earnings vs. Estimates